allogeneic hematopoietic stem cell transplantation + Pharmacological Study + CLOFARABINE + Melphalan + Sirolimus + Tacrolimus for myelodysplastic syndromes

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Jun 2013: Trial registered, NCT01885689
  2. 10 Feb 2014: Trial started, NCT01885689

The trials

NCT01885689: Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia

State
Under way
Phase
Phase 2
People
72 taking part
Started
10 Feb 2014
Primary completion
27 Dec 2019
Arms
Treatment (clofarabine, melphalan, transplant)
Results
Posted on the registry
  1. 25 Jun 2013: Trial registered
  2. 10 Feb 2014: Trial started
  3. 4 Apr 2023: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.